BCOP Test - The Role of the Pharmacist in Smoking Cessation and Education of Patients with Cancer |
|
06/08/2020 - 1:00pm to 06/08/2021 - 12:00am |
BCOP Test - Treatment Advances for Pediatric B-Cell Non-Hodgkin's Lymphomas |
|
11/17/2020 - 5:00pm to 11/17/2021 - 12:00am |
BCOP Test - Updates in the Treatment of Pancreatic Adenocarcinoma |
|
03/11/2021 - 2:00pm to 03/11/2022 - 12:00am |
BCOP Test - Updates on Targeted Therapy in the Treatment of Metastatic Colorectal Cancer |
|
04/06/2021 - 2:00pm to 04/06/2022 - 12:00am |
BCOP Test - Updates on the Use of Immunotherapy and Targeted Therapy in Non-Small Cell Lung Cancer |
|
05/21/2020 - 2:00pm to 05/21/2021 - 12:00am |
Biomarker Assays for Treatment Selection of Advanced Breast Cancer |
0.50 |
03/15/2020 - 12:00am to 03/15/2021 - 12:00am |
Bonanza of New Treatment Regimens for Multiple Myeloma: What is Right for My Patient? |
0.50 |
10/30/2020 - 12:00am to 10/30/2021 - 12:00am |
Cardiovascular Health and Risk Management in Cancer Survivors |
0.50 |
05/15/2020 - 12:00am to 03/01/2021 - 12:00am |
Chronic Lymphocytic Leukemia Patient Management Simulator |
|
06/08/2020 - 12:00am to 06/08/2021 - 12:00am |
Controversies in the Management of Early-Stage Hodgkin Lymphoma |
0.50 |
10/30/2020 - 12:00am to 10/30/2021 - 12:00am |
Current Insights: Evolving Principles and Controversies of Cancer Risk Assessment and Management of Hereditary Cancers |
1.25 |
05/15/2020 - 12:00am to 03/01/2021 - 12:00am |
Current Topics in Management of Non-Muscle Invasive Bladder Cancer |
0.75 |
05/15/2020 - 12:00am to 03/01/2021 - 12:00am |
Debate - What is Optimal First-Line Therapy for Chronic Lymphocytic Leukemia: Chemoimmunotherapy or Small Molecule Inhibitor Therapy? |
1.25 |
05/18/2020 - 12:00am to 03/01/2021 - 12:00am |
Emerging Therapeutic Options in Acute Lymphoblastic Leukemia |
0.50 |
10/30/2020 - 12:00am to 10/30/2021 - 12:00am |
Emerging Treatment Options for the Management of Metastatic Colorectal Cancer |
0.75 |
05/15/2020 - 12:00am to 03/01/2021 - 12:00am |